Table 1 Baseline data
Item | Phase I (11) | Phase II (27) | P |
|---|---|---|---|
Onset time, n (%) | 0.488 | ||
>6 h | 8 (72.73) | 16 (59.26) | |
<6 h | 3 (27.27) | 11 (40.74) | |
Male, n (%) | 10 (90.91) | 25 (92.59) | 1 |
Age (years) | 56 [20] | 52 [22] | 0.240 |
BMI (kg/m²) | 25.30 ± 3.90 | 26.62 ± 3.82 | 0.345 |
Hypertension, n (%) | 11 (100) | 22 (81.48) | 0.295 |
Diabetes, n (%) | 1 (9.09) | 4 (14.81) | 1 |
Abdominal pain (n, %) | 10 (90.91) | 24 (88.89) | 1 |
Bloody stool, n (%) | 6 (54.55) | 6 (81.48) | 0.068 |
AST (IU) | 289 [669] | 99 [210] | 0.288 |
ALT (IU) | 153 [254] | 98 [94] | 0.246 |
TBIL (µmol/L) | 25.35 ± 11.85 | 20.78 ± 11.05 | 0.265 |
Serum creatinine (mmol/L) | 128.22 ± 50.70 | 138.45 ± 84.62 | 0.711 |
Max serum lactate preoperative (mmol/L) | 3.95 ± 2.97 | 3.25 ± 2.21 | 0.432 |
LVEF (%) | 60.91 ± 2.39 | 59.89 ± 4.34 | 0.469 |
Moderate to severe AR, n (%) | 4 (36.36) | 10 (47.62) | 1 |
SMA obstruction types, n (%) | 0.900 | ||
Dynamic | 6 (54.55) | 15 (55.56) | |
Static | 3 (27.27) | 8 (29.63) | |
Mixed | 2 (18.18) | 4 (14.81) | |
Septic shock, n (%) | 5 (45.45) | 4 (14.81) | 0.088 |
Renal insufficiency, n (%) | 5 (45.45) | 11 (40.74) | 1 |
Hepatic insufficiency, n (%) | 5 (45.45) | 7 (25.93) | 0.272 |
Paraplegia, n (%) | 0 | 1 (3.70) | 1 |
Low extremity ischemia, n (%) | 3 (27.27) | 4 (14.81) | 0.390 |